Critical Updates in U.S. Patent Litigation: Key Cases and Strategic Implications for Pharma & Biotech

Taft Chicago partners Steve Auten and Roshan Shrestha, Ph.D. presented on “Critical Updates in U.S. Patent Litigation: Key Cases and Strategic Implications for Pharma & Biotech” at the IpEssentia webinar on Nov. 11, 2024. The program covered comprehensive insights into significant legal cases and emerging trends in the pharmaceutical industry involving skinny labeling and carve-outs, clinical trial disclosures and patent validity, and more.

Watch the full video here:

Or view a specific topic:

• About Taft – 00:00
• Case review: On-Sale Bar – 07:30
  • Celanese Intl Corp v. ITC
• Case review: Disclosures in Clinical Trials – 12:37
  • Janssen v. Teva
  • Salix v. Norwich
• Case review: Written Description/Enablement – 26:59
  • Baxalta v. Genentech
  • Medytox v. Galderma
• Case review: Skinny Label – 41:29
  • Amarin v. Hikma
  • Salix v. Norwich
• Case review: Obviousness-Type Double Patenting – 51:49
  • In re Cellect
  • Allergan v. MSN Labs
• Q&A and Conclusion – 01:05:23